Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J.
Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
1990
ISSN/ISBN: 0894-9255 PMID: 2231307 Document Number: 356363
Document emailed within 1 workday
Related Documents
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27DeMets, D.L. 1990: Methodological issues in AIDS clinical trials. Data monitoring and sequential analysis--an academic perspective Journal of Acquired Immune Deficiency Syndromes 3(Suppl 2): S124-S133
Feigal, E.G.; Phillips, P.H.; Cheson, B.D. 1997: Clinical Trials Referral Resource. Clinical trials in AIDS related malignancies Oncology 11(3): 337-338; 341
Overall, J.E. 1989: Design issues in clinical trials Progress in Clinical and Biological Research 317: 1291-1299
Gibson, R.S.; Sazawal, S.; Peerson, J.M. 2003: Design and quality control issues related to dietary assessment, randomized clinical trials and meta-analysis of field-based studies in developing countries Journal of Nutrition 133(5 Suppl 1): 1569s-1573s
Fleming, T.R. 1999: Issues in the design of clinical trials: insights from the trastuzumab (Herceptin) experience Seminars in Oncology 26(4 Suppl. 12): 102-107
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570
Boissel, J.P. 1989: Subcommittee on Clinical Trials. Registry of multicenter clinical trials. Tenth report--1988 Thrombosis and Haemostasis 62(4): 1126-1142
Cheson, B.D.; Abrams, J.S.; Arbuck, S.G.; Phillips, P.H. 1994: Clinical trials referral resource. Clinical trials with paclitaxel in metastatic breast cancer Oncology 8(1): 72
Zhao, Y.-m. 2010: Targets and principles for system design of quality control in clinical trials Zhonghua Yi Xue Za Zhi 90(26): 1801-1803
Davis, T.; Schoenfeldt, M.; Chevalier, S.M. 2005: Clinical trials referral resource. Current clinical trials in myelodysplastic syndrome Oncology 19(8): 1035-1036; 1038
Trimble, E.; Valmonte, C.M.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials in cervical cancer Oncology 14(7): 1045-1046; 1049-1050
Ivy, S.P.; Blatner, G.; Cheson, B.D. 1999: Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin Oncology 13(8): 1116-1118
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current clinical trials in multiple myeloma Oncology 18(2): 196-198; 203